Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALTEROLA BIOTECH, INC.

(ABTI)
SummaryQuotesChartsNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

ALTEROLA BIOTECH INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)

05/25/2021 | 04:03pm EDT

ITEM 1.01 - ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

On January 19, 2021, Alterola Biotech, Inc. (the "Company") entered into an Stock Transfer Agreement (the "Agreement") with ABTI Pharma Limited, a company registered in England and Wales ("ABTI Pharma"), pursuant to which the Company will acquire all of the outstanding shares of capital stock of ABTI Pharma from its shareholders in exchange for 600,000,000 shares of the Company pro rata to the ABT Pharma shareholders.

On May 24, 2021, the Company and the shareholders of ABTI Pharma memorialized a new closing date in an amendment to the Agreement (the "Amendment"). We have already issued the 600,000,000 shares in anticipation of the closing and the transaction will close upon the ABTI Pharma shares being transferred to the Company, which will occur upon the filing of the Company's December 31, 2020 quarterly report on Form 10-Q with the Securities and Exchange Commission.

The foregoing description of the Amendment is a summary, does not purport to be complete, and is qualified in its entirety by reference to the full text of the Amendment, a copy of which is attached as Exhibit 2.1 to this Current Report on Form 8-K and incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.




Exhibit No. Description
2.1           Amendment to Stock Transfer Agreement, dated May 24, 2021




  3

© Edgar Online, source Glimpses

All news about ALTEROLA BIOTECH, INC.
08/19ALTEROLA BIOTECH : Management's Discussion and Analysis of Financial Condition a..
AQ
08/02ALTEROLA BIOTECH : acquires ABTI pharma ltd
AQ
06/21ALTEROLA BIOTECH INC. : Change in Directors or Principal Officers (form 8-K)
AQ
06/16ALTEROLA BIOTECH INC. : Entry into a Material Definitive Agreement, Completion o..
AQ
06/16ABTI Pharma Limited completed the acquisition of Alterola Biotech, Inc. in re..
CI
06/09ALTEROLA BIOTECH : 10-KT - Management's Discussion and Analysis of Financial Con..
AQ
06/09Alterola Biotech, Inc. Reports Earnings Results for the Half Year Ended March..
CI
06/09ALTEROLA BIOTECH INC. : Amendments to Articles of Inc. or Bylaws; Change in Fisc..
AQ
05/28ALTEROLA BIOTECH : Management's Discussion and Analysis of Financial Condition a..
AQ
05/25ALTEROLA BIOTECH INC. : Entry into a Material Definitive Agreement, Financial St..
AQ
More news
Chart ALTEROLA BIOTECH, INC.
Duration : Period :
Alterola Biotech, Inc. Technical Analysis Chart | ABTI | US02152V1035 | MarketScreener
Managers and Directors
Seamus McAuley Chief Executive Officer
Larson Elmore Vice Chairman, CFO, Secretary & CAO
Timothy Paul Rogers Chairman
Colin Stott Chief Operating Officer & Director
Dominic Schiller Director
Sector and Competitors
1st jan.Capi. (M$)
ALTEROLA BIOTECH, INC.0.00%950
GILEAD SCIENCES, INC.22.91%89 785
BIONTECH SE340.60%86 750
REGENERON PHARMACEUTICALS34.93%67 775
WUXI APPTEC CO., LTD.35.75%60 418
VERTEX PHARMACEUTICALS-20.33%48 850